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ABSTRACT:Melanocortin 2 receptor accessory protein (MRAP) is a single transmembrane domain accessory protein
and a critical component of the hypothamo-pituitary-adrenal axis. MRAP is highly expressed in the adrenal gland
and is essential for adrenocorticotropinhormone (ACTH) receptor expressionand function.Human loss-of-function
mutations inMRAP cause familial glucocorticoid (GC) deficiency (FGD) type 2 (FGD2),whereby the adrenal gland
fails to respond toACTHand toproducecortisol. In this study,wegeneratedMrap-nullmice to study the functionof
MRAP invivo.Wefound that thevastmajorityofMrap2/2micediedatbirthbut couldbe rescuedbyadministration
of corticosterone to pregnant dams. SurvivingMrap2/2mice developed isolated GC deficiency with normal min-
eralocorticoid and catecholamine production, recapitulating FGD2. The adrenal glands of adultMrap2/2micewere
small, with grossly impaired adrenal capsularmorphology and cortex zonation. Progenitor cell differentiation was
significantly impaired, with dysregulation of WNT4/b-catenin and sonic hedgehog pathways. These data dem-
onstrate the roles of MRAP in both steroidogenesis and the regulation of adrenal cortex zonation. This is the first
mouse model of isolated GC deficiency and reveals the role of MRAP in adrenal progenitor cell regulation and
cortex zonation.—Novoselova, T. V., Hussain,M., King, P. J., Guasti, L.,Metherell, L. A., Charalambous,M., Clark,
A. J. L., Chan, L. F. MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. FASEB J.
32, 6186–6196 (2018). www.fasebj.org
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Melanocortin receptor accessory proteins (MRAPs) are a
class of single-pass transmembrane domain accessory
protein (1–3). MRAP and MRAP2 have been shown to
interact in vitrowith themelanocortin receptors (MCRs), a
family of GPCRswith diverse physiological functions that
are stimulated by pro-opiomelanocortin–derived peptide
agonists. MRAP2 is implicated inmetabolic regulation via
its interaction with MC4R, although other mechanisms
may be involved (2, 4–7).
MRAP is essential for the function of the adrenocorti-
cotropin hormone (ACTH) receptor/melanocortin 2 re-
ceptor (MC2R) and is highly expressed in adrenal glands
(1). MRAP has been shown to form unique antiparallel
homodimers that complex with, and assist, MC2R traf-
ficking and signaling (8–10). The MRAP/MC2R complex
on the surface of adrenocortical cells is essential tomediate
the action of pituitary ACTH and subsequent steroidogen-
esis. Mutations inMC2R account for up to 25% of cases of
familial glucocorticoid (GC)deficiency (FGD) type1 (FGD1;
OMIM:202200) (11, 12). FGD manifests in early childhood
with hypoglycemia, lethargy, and overwhelming infection
due to isolated GC deficiency while maintaining normal
aldosterone levels. Mutations inMRAP are responsible for
;20% of cases of FGD type 2 (FGD2; OMIM: 609196) and
cause earlier disease onset compared with FGD1 (13).
Hormones secreted from the three concentric zones of
the adrenal cortex are vital for life and general well-being.
Mineralocorticoids (aldosterone) from the outer zona
glomerulosa (ZG) regulate electrolyte levels and blood
pressure. The inner zona fasciculata (ZF) is responsible for
GC production (cortisol in humans and corticosterone in
the majority of rodents, except the spiny mouse that pro-
duces cortisol) and is important for the stress response and
formetabolic and immune function. Themostmedialzona
ABBREVIATIONS: ACTH, adrenocorticotropin hormone; FGD, familial
glucocorticoid deficiency; GC, glucocorticoid; H&E, hematoxylin and
eosin; MC2R, melanocortin 2 receptor; MRAP, melanocortin 2 receptor
accessory protein; qRT-PCR, quantitative RT-PCR; SHH, sonic hedgehog;
ZF, zona fasciculata; ZG, zona glomerulosa; ZR, zona reticularis
1 Correspondence: Centre for Endocrinology, William Harvey Research
Institute, Barts and the London School of Medicine, Queen Mary Uni-
versity of London, Charterhouse Square, EC1M 6BQ London, United
Kingdom. E-mail: l.chan@qmul.ac.uk
This is an Open Access article distributed under the terms of the
Creative Commons Attribution 4.0 International (CC BY 4.0) (http://
creativecommons.org/licenses/by/4.0/) which permits unrestricted use,
distribution, and reproduction in any medium, provided the original
work is properly cited.
doi: 10.1096/fj.201701274RR
This article includes supplemental data. Please visit http://www.fasebj.org to
obtain this information.
6186 0892-6638/18/0032-6186 © The Author(s)
Downloaded from www.fasebj.org by (88.111.86.27) on November 08, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6186-6196.
reticularis (ZR) in humans secretes adrenal androgens that
control adrenarche in puberty. Unlike in humans, the in-
nermost zone in mice is called the X zone. This distinct
zone is the remaining remnants of the fetal zone, which
regresses during the first pregnancy in femalemice and at
puberty in male mice (14). The mechanisms controlling
adrenal cortex zonation and cell renewal are under in-
creasing scrutiny and have been implicated in adrenal
diseases, tumorigenesis, and aging (15, 16). In particular,
the adrenal capsule, a thin covering of cells adjacent to the
ZG, and the subscapular region are thought to house the
pool of adrenal stem/progenitor cells capable of dividing,
migrating centripetally, and differentiating into mature
steroid-producing cell types (15–17). A number of para-
crine and endocrine factors have been implicated in ad-
renal zonation and renewal, including sonic hedgehog
(SHH) signaling, WNT/b-catenin pathways, and, more
recently, ACTH-mediated PKAactivation (15, 18, 19). Our
previouswork, localizingMRAPtotheundifferentiatedzone
of the rat adrenal gland, allowed us to question the impor-
tance of MRAP in adrenal cell differentiation and mainte-
nance (20). In this study, we generated Mrap2/2 mice to
investigate the function of MRAP in FGD pathophysiology
and its role in adrenocortical development andmaintenance.
MATERIALS AND METHODS
Generation of Mrap2/2 mice
Design of targeting vector and generation of Mrap2/2 mice was
performed byGenoway (Lyon, France). The strategy is illustrated in
Fig. 1A. Briefly, the genomic region of interestwas amplified byPCR
and cloned into the targeting vector containing a neomycin selection
cassette flanked by flippase recognition target sites and loxP flanking
sites. All PCR fragments were validated by DNA sequencing. The
targeting vector was electroporated into C57Bl/6 ES cells. G418-
resistant clones were harvested and screened by PCR and Southern
blot analysis. The recombined ES cell clones were microinjected into
C57BL/6J blastocysts. To generate globalMrap2/2mice, male mice
with the Mrap recombined locus were bred with female mice
expressingFlprecombinasetoremovetheselectablemarker.Animals
were bred with germline Cre delete mice to excise exon 1 ofMrap.
Animal husbandry, procedures, and
hormone analysis
Thecareanduseof all animalswerecarriedout inaccordancewith
the United KingdomHome Office Regulations, United Kingdom
Animals (Scientific Procedures). Mice were kept under standard
12-h light/dark cycle with food andwater ad libitum unless stated
otherwise. Corticosterone hormone replacement was performed
by administering 50 mg/ml in drinking water to breeder cages
starting embryonic day (E)17.5; drinking water was changed
daily.The treatmentwasstoppedatweaning [postnatalday (P)21]
or continued until 8wk of lifetime corticosterone replacement. An
ACTH stimulation test was performed in the morning by in-
traperitoneal injection of 10 ng/g synacthen (Alliance Pharma-
ceutical, Chippenham, United Kingdom). Mice were euthanized
byexsanguination1hafter injection. ForACTHmeasurement, the
animalswere fasted for 16h followedby exsanguination. Twenty-
four–hoururinewas collectedusingmetabolic cages.Heparinized
plasma was subject to ELISA for corticosterone and aldosterone
(KGE009 and KGE016, respectively; R&D Systems, Abingdon,
United Kingdom). ACTHwas measured using a 6-Plex Luminex
Assay (Thermo Fisher Scientific, Cheshire, United Kingdom).
Urine catecholamines and creatinine were assessed by HPLC.
Histology and histochemistry
Tissues were fixed in ice-cold 4% paraformaldehyde in PBS fol-
lowed by paraffin embedding for hematoxylin and eosin (H&E)
staining. For immunohistochemistry, tissues were cryoprotected
with 20% sucrose in PBS after fixation followed by cryosectioning
andheat-mediated antigen retrievalwith citric buffer (10mM,pH
6.0) as previously described (18). The primary antibodies used in
this studywere rabbit anti-MRAP1/20 (10);mouseanti-CYP11B1
and rabbit anti-CYP11B2, both 1/50 (kind gift ofDr. C. E.Gomez-
Sanches, University of Mississippi, Jackson, MI, USA); rabbit anti-
PNMT 1/250 (Abcam, Cambridge, United Kingdom); mouse
anti–b-catenin 1/300 (MilliporeSigma, Cambridge, United
Kingdom); rabbit anti-WNT4 1/20 (Abcam); mouse anti-StAR
1/400 (Abcam), rabbit anti-20aHSD (1/5000, kind gift from Y.
Weinstein, Israel), rabbit anti-DAB2 1:200 (Santa Cruz Bio-
technology, Dallas, TX, USA), and rabbit anti-LEF1 1/100
(Abcam). In situ hybridization was performed as described by
Guasti et al. (21). TheShh sequence used forRNAprobe synthesis
was derived from adult mouse adrenal cDNA using the primers
forward, 59-ATGCTGCTGCTGCTGGCCAGATG-39 and re-
verse, 59-GGGCCCCGAGTCGTTGTGCGGCG-39. The 849 bp
fragmentwas then ligated into pGEM-Teasy (Promega,Madison,
WI, USA) and confirmed by Sanger sequencing. T7 and SP6
(Roche, Basel, Switzerland) were used for in vitro translation to
produce the riboprobe. Capsule counts were performed using at
least eight H&E-stained sections cut approximately through the
middle, and capsule thickness (mm) was measured using the
average of at least threemeasurements for each section analyzed.
The images were analyzed and processed using Leica LAS AF
(LeicaMicrosystems,Wetzlar, Germany), Adobe Photoshop, and
Adobe Illustrator (San Jose, CA, USA).
Western blotting
Adrenal glands were lysed in 23 Laemmli sample buffer, soni-
cated for 10 s, and centrifuged at 13,000 g for 15 min. The samples
were thendenaturedfor1hat37°Candloadedonto4–12%Bis-Tris
NovexAcrylamideGel (ThermoFisherScientific).Westernblotting
was performed per standard protocol and immunostained using
rabbit anti-MRAPantibody1/500andmouseanti-actinb1/10,000
(Abcam), anti-rabbitOdysseyLi-Cor 800, andanti-mouseOdyssey
Li-Cor 680 secondary antibodies andvisualizedusing theOdyssey
Fc Imaging System (Li-Cor Biosciences, Lincoln, NE, USA).
Quantitative RT-PCR
The tissue was dissected and immediately placed in liquid nitro-
gen. RNA was then extracted using the RNAsy Kit (Qiagen,
Hilden,Germany), and1mgofRNAwasused for cDNAsynthesis
using SuperScript IV RT (Thermo Fisher Scientific). TaqMan pre-
designed assays (Thermo Fisher Scientific, listed in Supplemental
Data, and Supplemental Table 1) were then performed according
to the manufacturer’s protocol, including no template or reverse
transcription control, and analyzed using the DCt method.
Statistical analysis
All values were calculated as means6 SEM. Comparisons of two
groupswereanalyzedbyStudent’s t test. Formore than2groups,
1-wayANOVAwas performed followed by Bonferroni multiple
comparison test. In all analyses, a 2-tailed probability of P, 0.05
was considered statistically significant.
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RESULTS
Generation and production of Mrap2/2 mice
Mrap2/2 mice were produced by deletion of exon 1 of
Mrap (Fig. 1A). No Mrap transcript was detected in the
knock-out animals, whereas Mrap+/2 mice produced
approximately half of the transcript level found in the
wild-type littermates (Fig. 1B). The lack of protein
expression inMrap2/2mice was confirmed using an anti-
MRAP antibody. Immunoblotting demonstrated a stable
homodimer of MRAP, with electrophoretic mobility of
;35 kDa in the adrenal gland ofMrap+/+ mice but not in
the mutant (Fig. 1C). Immunohistochemistry showed
Figure 1. Generation ofMrap2/2
mice. A) Schematic represen-
tation of targeting of the exon 1
of Mrap mouse for the line
production. B) qRT-PCR analy-
sis of Mrap expression in the
adrenal gland ofMrap+/+ (n = 7),
Mrap+/2 (n = 7), and Mrap2/2
(n = 4) mice showing that
Mrap+/2 mice express approxi-
mately half of the Mrap tran-
script found in the wild-type
adrenals, whereas no transcript
was detected in Mrap2/2adre-
nals. ***P , 0.0005, Student’s
t-test. C) Immunoblotting of
adrenal gland lysates from
Mrap+/+ and Mrap2/2 mice with
anti-MRAP and anti–actin b
(ACTB) antibodies. The arrows
on the left indicate the approx-
imate MW position. The posi-
tion of the main band inMrap+/+
corresponds to the anticipated
size of a mature MRAP dimer,
with the lower band represent-
ing the nonglycosylated form. D)
Immunostaining of MRAP (red)
in the adrenal gland of Mrap+/+
(top panel) and Mrap2/2 mice
(bottom panel). The nuclei are
stained with DAPI (blue). The
adrenal zonation is marked in
the wild-type gland as follows: C,
capsule; M, medulla; WAT,
white adipose tissue; XZ, X-zone.
Scale bars, 100 mm. E) Repre-
sentative images of the adrenals
from the Mrap+/+ and Mrap2/2
mice sectioned though the mid-
dle of the organ, demonstrating
the reduction in the gland’s size.
The black boxes indicate the
where the higher-magniﬁcation
images were obtained. Scale
bars, 200 mm. F) Adrenal gland
zonation is impaired in Mrap2/2
mice (right panel) compared
with Mrap+/+ mice (left panel)
as shown by the H&E staining.
Panel images are from female
mice, although similar adrenal
gland zonation impairment is
seen in male mice (data not
shown). Adrenal gland zonation
in male mice: C, capsule; M,
medulla; XZ, X zone. The zona-
tion in theMrap2/2 adrenal gland
is not deﬁned. Scale bars, 50 mm.
6188 Vol. 32 November 2018 NOVOSELOVA ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by (88.111.86.27) on November 08, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6186-6196.
that MRAP is detected mostly in the ZF in the wild-type
adrenal gland with some staining in the X zone (Fig. 1D
andSupplemental Fig. 1). This stainingwasnot observed
in the adrenal gland of Mrap2/2 mice, consistent with
the absence of MRAP protein production (Fig. 1D).
Mrap deficiency was associated with neonatal
lethality, which was prevented with
corticosterone replacement
Of the 325mice generated fromMrap+/2 intercrosses, only
three Mrap2/2 mice survived until weaning without cor-
ticosterone replacement. Mrap2/2 mice were usually
found dead before P0.5 without milk in their stomach.
Excised lungs fromdeceased neonatalMrap2/2mice sank
when submerged in water/saline, suggesting a failure of
lung inflation. It is known that fetalGCsplay an important
role in fetalpreparation forneonatal lifeby facilitating lung
maturation and hepatic glycogen accumulation. We ex-
amined E19.5 embryos and found that the lungs of the
mutant mice resembled immature lungs prior to terminal
differentiation of the alveoli (Supplemental Fig. 2A).Mrap
mRNA was not detected in wild-type fetal (at E15.5;
Supplemental Fig. S2B) or adult lungs (Supplemental Fig.
2C) by quantitative RT-PCR (qRT-PCR), and fetal lungs
stained negatively for Mrap expression by in situ hybrid-
ization at E14.5 (Supplemental Fig. 2D). Glycogen storage
in the liver of Mrap2/2 E19.5 preterm embryos was re-
duced compared with Mrap+/+ littermate controls (Sup-
plemental Fig. 2E). These findings suggested that the pups
probably died of failure to breathe and/or defective neo-
natal nutritional adaptation due to GC deficiency. There-
fore, to produce Mrap2/2 mice and matched Mrap+/+
littermate controls, we intercrossed Mrap+/2 mice and
administered corticosterone in the drinkingwater (50mg/
ml) of pregnant dams from E17.5 until weaning of the
pups on P21. With this strategy, the survival ofMrap2/2
mice atweaningwas close to the expected rate [61 (24.7%)
Mrap2/2, 115 (46.7%) Mrap+/2, and 70 (28%) Mrap+/+].
Mrap2/2 mice were visually indistinguishable from their
wild-type, sex-matched littermates who had also received
corticosterone from E17.5 until weaning. After weaning,
the mice no longer received corticosterone in the drinking
water. No adult mortality was noted in the surviving
Mrap2/2 mice, and both female and male Mrap2/2 mice
were fertile.
Surviving Mrap2/2 mice develop isolated
GC deficiency
Adrenal glands in Mrap2/2 mice were macroscopically
detectable but significantly reduced in size at 8 wk (Fig.
1E). This is in contrast to the relatively similar adrenal
gland sizes between fetal Mrap2/2 and Mrap+/+ mice at
E19.5 (Supplemental Fig. 3). Histologic analysis of adult
adrenal glands revealed grossly abnormal zonation of the
adrenal cortex in bothmale and femaleMrap2/2mice (Fig.
1F). Immunohistochemistry demonstrated that the adre-
nal glands in Mrap2/2 mice were negative for CYP11B1,
the key terminal enzyme essential for corticosterone
production, suggesting the absence of GC-producing cells
(Fig. 2A). Expression of CYP11B2, the key enzyme for al-
dosteroneproduction,was restricted to theZG in thewild-
type mice, whereas in the Mrap2/2 adrenals CYP11B2
stained a larger proportion of cells, with positive cells
seemingly taking over large parts of the cortex (Fig. 2B).
The adrenal medulla appeared to be unaffected as
assessed by PNMT staining (Fig. 2C).
Studying adrenal gland steroidogenic enzyme expres-
sion more broadly, RNA levels of Cyp11a1, Hsd3b1,
Cyp21a1, and Cyp11b1 as well as Sf-1 and Star (steroido-
genic acute regulatory protein) were significantly de-
creased in the adrenals of Mrap2/2 mice (Fig. 3A)
compared with wild-type, sex-matched littermates. The
expression of the key enzyme of the aldosterone synthesis
pathway, Cyp11b2, was not affected. These findings, to-
gether with histologic staining of CYP11B2-positive cells,
suggest that this pathway is likely to remain functional.
There were no changes of Mc2r expression in Mrap2/2
mice. Low Mrap2 transcript levels detected in Mrap+/+
mice adrenalswere unchanged inMrap2/2mice (Fig. 3A),
indicating that MRAP’s only ortholog, Mrap2, is unlikely
to compensate for the loss ofMrap expression at the RNA
level. This is in keeping with previous in vitro data that
much higher concentrations ofMrap2 are required for the
functional expression of MC2R (20).
To investigate the physiological effects of Mrap gene
deletion, we examined the response of mutant mice to
exogenously administered ACTH. We could not detect
corticosterone in Mrap2/2 mice either basally or after
ACTH stimulation, whereasACTH response inwild-type
mice was present in both genders (Fig. 3B and Supple-
mental Fig. 3A). ACTH response in both male and female
Mrap+/2micewas intact and similar toMrap+/+ littermates
(Supplemental Fig. 3C, D). The levels of plasma ACTH
were greatly increased in Mrap2/2 mice compared with
Mrap+/+mice (Fig. 3C). Thus,Mrap2/2micedemonstrated
ACTH resistance.
Aldosterone levels were unaffected in mutant mice of
both genders (Fig. 3D and Supplemental Fig. 3B), as were
urinary catecholamine concentrations (Fig. 3E, F). This
Mrap2/2 mouse phenotype differs from Mc2r2/2 mice,
which have been reported to have partial aldosterone and
catecholaminedeficiency in addition toGCdeficiency (22).
The Mrap2/2 mouse therefore closely replicates the hu-
man FGD phenotype of isolated GC deficiency.
Mrap2/2 adrenal glands have a thickened
capsular layer, which was partially rescued
with GC treatment
The adrenal capsule of 8-wk-old Mrap2/2 mice was
thickened compared with the wild-type littermates in ab-
solute measurement (in micrometers) (Fig. 4A). The cap-
sule thicknesswas due to an increase in cell number rather
than extracellular matrix expansion (Fig. 4A and Supple-
mental Fig. 4A). This capsular phenotype is established
prior to birth (Supplemental Fig. 3E). Studies have dem-
onstrated the importance of the adrenal capsule in the
control of adrenocortical cell renewal and zonation (15,
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Figure 2. Impaired zonation in the adrenal cortex of the Mrap2/2 mice. A) Severely reduced immunostaining of CYP11B1
(green) in Mrap2/2 adrenal glands. B) CYP11B2 (red) localization in Mrap+/+ and Mrap2/2 adrenal glands. C) PNMT (red) in
the adrenal medulla of Mrap+/+ and Mrap2/2 mice. The cell nuclei are stained with DAPI (blue). CX, cortex; M, medulla. Scale
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Figure 3. ACTH resistance and isolated GC deﬁciency of Mrap2/2 mice. A) qRT-PCR of the adrenal gland of male Mrap+/+ and
Mrap2/2 mice (n = 4 for each group) shows down-regulation of the steroidogenic pathway. B) Plasma corticosterone levels
(ng/ml) at the basal level and in response to ACTH stimulation in male Mrap+/+ (n = 7) and Mrap2/2 (n = 7) mice. C) ACTH
levels (pg/ml) in male Mrap+/+ (n = 6) and Mrap2/2 (n = 5) mice. D) Comparison of plasma aldosterone levels (pg/ml) between
the genotypes in male mice (Mrap+/+, n = 7; Mrap2/2, n = 7). E, F) Epinephrine (E) and norepinephrine (F) levels in the 24-h
urine of male Mrap+/+ (n = 6) and Mrap2/2 (n = 5) mice assessed as the ratio to creatinine to adjust for the kidney function.
Student’s t test used for comparison of 2 groups. *P , 0.05, **P , 0.005, ***P , 0.0005. 1-way ANOVA for more than 2 groups.
*P , 0.05, **P , 0.01, ***P , 0.001. NS, not signiﬁcant.
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18). More recently, PKA and ACTH signaling have been
implicated in the regulation of adrenal zonation de-
termining the ZG/ZF border (23).
To elucidate whether the adrenal capsular phenotype
was due to the lack of ACTH signaling or the absence of
GCs,weperformed corticosterone replacement ofMrap2/2
mice and sex-matched, wild-type littermates after
weaning. In this case, drinkingwater was supplemented
with corticosterone starting at E17.5 until 8 wk of age
when the phenotype was assessed. With this strategy,
which we call “lifetime corticosterone treatment,” corti-
costerone levels between the wild-type and Mrap2/2
littermates were normalized (Supplemental Fig. 4B).
Examination of the capsule of Mrap2/2 mice that had
received lifetime corticosterone treatment revealed that
chronic GC administration partially reduced the thickness
of the capsular layer, suggesting that GC depletion partly
contributed to the capsular phenotype independent of
ACTH signaling (Fig. 4B, C). The absence of ACTH sig-
naling is likely to further contribute to capsule thickness, as
demonstrated by an increase in thickness in corticosterone-
treated, wild-type mice, with normalized corticosterone
levels and low ACTH (Fig. 4C). Furthermore, capsule
thickness inMrap2/2GC-treatedmice remains significantly
greater compared with Mrap+/+ GC-treated mice, which
would suggest an MRAP-independent effect (Fig. 4C).
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Shh signaling is altered in Mrap2/2 adrenal
glands and is not normalized by treatment
with GCs
SHH signaling is one of the key pathways regulating ad-
renal zonation and identifies progenitors of steroidogenic
lineages (18, 21). The expression of Shhwas quantitatively
increased in theadrenal glandsofMrap2/2micecompared
with the wild-type littermates (Fig. 4D). In situ hybrid-
ization demonstrated Shh-positive cells throughout the
adrenal cortex in Mrap2/2 mice, as opposed to the
expected subcapsular localization observed in wild-type
adrenals (Fig. 4E). These data suggest that loss of MRAP-
mediatedACTH signaling and/or GCdepletion could be
the cause of SHH progenitor accumulation. Lifetime cor-
ticosterone replacement did not reverse this phenotype,
indicating that the Shh pathway is likely to depend on
MRAP-mediated ACTH signaling rather than on GC
levels (Fig. 4F). Shh expression measured by qRT-PCR
after GC was also statistically unchanged in Mrap2/2
mice. Expression of Gli1, a transcriptional target of SHH
signaling in the adrenal gland (18), was unaffected in the
adrenals of Mrap2/2 mice (Supplemental Fig. 4C). The
expression of other GLI family members (Gli2 and Gli3)
was also unchanged (Supplemental Fig. 4D, E).
b-Catenin signaling is dysregulated in the
adrenal cortex of Mrap2/2 mice
Recent studies implicated canonical wnt/b-catenin sig-
naling in adrenal gland zonation (23–25). Therefore, we
tested the function of this pathway in the adrenals of
Mrap2/2mice. Immunostaining for WNT4 and b-catenin
demonstrated expression in the ZG in wild-type, mice as
previously reported (Fig. 5A). Mrap2/2 mice demon-
strated WNT4 and b-catenin staining throughout the ad-
renal cortex in both lifetime corticosterone-replaced and
nonreplaced animals (Fig. 5A, B).
Expression of WNT4 and b-catenin is associated with
ZG cell identity (26, 27). Therefore, we examined the ex-
pression of CYP11B2 in these cells. It appeared that some
of the cells that were positive for WNT4 and b-catenin
expressionwerenegative forCYP11B2andhencewerenot
aldosteroneproducing (Fig. 5A andSupplemental Fig. 4F).
These cells were also negative for DAB2, another ZG-
specificmarker (Supplemental Fig. 4G). ExpressionofLef1,
a downstream component of the b-catenin pathway, was
not affected in Mrap2/2 mice (Fig. 5A). The level of Lef1
mRNA expression was increased in Mrap2/2 adrenals
after lifetime GC treatment (Supplemental Fig. 4H). In
wild-typemice, immunohistochemistry showed thatLEF1
was localized to thenuclei of theZG(Fig. 5A) aspreviously
reported (28). LEF1-positive cells in Mrap2/2 adrenal
glandswere also found to be expressedmorewidely in the
cortex compared with wild-type mice, although LEF1-
positive cells did not penetrate as deeply into the cortex
comparedwithWNT4 andb-catenin cells (Fig. 5A). There
was no effect in response to chronic GC administration on
LEF1 distribution, suggestingGCs are unlikely to regulate
this signaling pathway (Fig. 5B).
AXIN-2 is another transcriptional target of the canoni-
cal b-catenin pathway. Consistent with previous reports
(14), expression of Axin2 was increased upon chronic GC
administration (Supplemental Fig. 4I). Similar to Lef1 ex-
pression, Axin2 levels in untreated Mrap2/2 mice were
similar to the wild-type littermates, and mutant mice
responded to GC treatment by an increase in Axin2 ex-
pression; however, this response was less prominent
compared with that observed in wild-type mice (Fig. 5A,
B). These findings suggest that, although WNT4 and
b-catenin are accumulated in the vast majority of cells
throughout the cortex of the Mrap2/2 adrenals, their
transcription targets LEF1, AXIN-2, and CYP11B2 are ac-
tivated only in a proportion of these cells. The adrenal
cortical cells in theMrap2/2mice, including those negative
for CYP11B2 and LEF1, showed impairment of the ste-
roidogenic potential as assessed by StAR immunostaining
(Fig. 5C). TheWNT4andb-catenin–positivebutCYP11B2-
negative cells were also negative for 20a-hydroxysteroid
dehydrogenase (20-aHSD), suggesting that they were not
fetal X-zone cells (29) (Fig. 5D). Furthermore, lifetime
treatment with GCs was capable of normalizing the
CYP11B2 phenotype in Mrap2/2 mice without changing
the LEF1 or AXIN-2 phenotypes (Fig. 5A, B).
DISCUSSION
Wepreviously identifiedmutations inMRAPas a cause of
FGD2.Herewedescribe the firstMrap2/2mousemodel of
ACTH resistance with isolated GC deficiency, represen-
tative of patients with FGD2. This study demonstrates the
importance ofMRAP in adrenal physiology. Furthermore,
we show the importance of MRAP in adrenal progenitor
cell differentiation and adrenal cortex zonation. In view of
the relativepostnatal reduction in adrenal sizes inMrap2/2
mice, MRAP is likely to also play a role in adrenal gland
maintenance and self-renewal.
PatientswithMRAPmutations are diagnosed earlier in
the neonatal period compared with those with MC2R
mutations (13); this correlates with the higher neonatal
death rates observed in Mrap2/2 mice. Mrap2/2 pups
died due to impaired maturation of the lungs, rescued by
corticosterone administration, indicating that this pheno-
type is due to corticosterone depletion rather than a direct
role of Mrap deficiency. Mc2r2/2 pups born from homo-
zygous parents died before P0.5 due to lung failure, sug-
gesting that fetal or maternal corticosterone is important
for lung maturation (30). Mrap+/2 breeders with normal
adrenal function and ACTH responsiveness delivered
Mrap2/2 pups with uninflated lungs. This finding high-
lights the importance of fetal rather than maternal gluco-
corticoids inprepartumlungmaturation.Wealsoobserved
depleted glycogen stores in prebirth embryos, which
would lead to compromised nutritional adaptation, se-
vere hypoglycemia, and neonatal death, as described for
Mc2r2/2mice (22). Furthermore, we were able to rescue
neonatal Mrap2/2 lethality by the administration of
corticosterone in drinking water from E19.5 until wean-
ing. After weaning, Mrap2/2 mice with undetectable
corticosterone levels survived.
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Adult Mrap2/2 mice exhibited gross morphologic
changes in the adrenal cortex and disturbances of the ste-
roidogenic pathway, with total absence of circulating
corticosterone.Despite this severe phenotype, aldosterone
levels were similar to those in the wild-type littermates.
The lack of StAR staining by immunohistochemisty of
Mrap2/2-derived adrenals may represent the inability of
the StAR antibody to detect low levels of StAR, measur-
able by qRT-PCR, that enable normal aldosterone
production in picogram per milliliter concentra-
tions. The adrenal medulla, histologically and func-
tionally, appeared to be unaffected. PMNT, an enzyme
responsible for conversionof noradrenaline to adrenaline,
is expressed in the medulla of corticosterone-deficient
Mrap2/2mice. This is surprisingbecause the expressionof
PNMT is known to be dependent on GCs (31, 32). There
is suggestion of a reduction in PNMT mRNA levels
in Mrap2/2 mice by qRT-PCR, although this was not
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Figure 5. Dysregulation of WNT4/b-catenin
signaling in Mrap2/2 mice. A) Immunohisto-
chemistry showing localization of b-catenin
(b-CAT), WNT4, CYP11B2, and LEF1 in the
adrenal glands of Mrap+/+ and Mrap2/2 mice.
B) Immunohistochemistry showing b-CAT,
WNT4, CYP11B2, and LEF1 in response to
lifetime corticosterone replacement. Cell nu-
clei are stained with DAPI as blue, with the
exception if LEF1 images where the nuclei are
stained green to highlight colocalization of
LEF1 with nuclei. CX, cortex; M, medulla.
Scale bar, 50 mm. C) Immunohistochemistry
with anti-StAR antibody shows impairment of
steroidogenic potential of the cells in the
adrenal cortex of Mrap2/2 mice. D) Immu-
nostaining of the adrenal glands with anti-
20aHSD antibody shows staining surrounding
the medulla in both wild-type and mutant
mice. CX, cortex; M, medulla; XZ, X zone.
Dashed line indicates medullary boundary.
Scale bars, 50 mm.
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statistically significant. Furthermore, PNMT activity is
clearly adequate for the production of adrenaline in
Mrap2/2 mice, which was statistically indifferent to the
adrenaline levels in Mrap+/+ littermates at 8 wk of age.
However, our mice (both genotypes) received relatively
high doses of GCs between E17.5 until weaning; hence,
it is unclear if this is sufficient for medullary PMNT
expression in the first instance. The absence of mineralo-
corticoid and the catecholamine deficiency in Mrap2/2
mice make this model uniquely different from the pre-
viously reported Mc2r2/2 mice, which exhibited low al-
dosterone and catecholamines levels (22).
The capsule of Mrap2/2 adrenals was thickened with
increased cell number; a similar change is seen inMc2r2/2
adrenal glands (22), suggesting that this phenotype is
likely due to a lack of ACTH signaling and/or GC pro-
duction. Our data demonstrate the importance of both
GCs and ACTH in capsule thickness. Lifetime GC re-
placement in Mrap2/2 mice partially normalized the
thickened adrenal capsule of Mrap2/2 mice, whereas
ACTHdeficiency in lifetimeGC-treatedwild-typeanimals
resulted in an increase in adrenal capsule thickness.
Moreover, our data suggest that MRAP may indepen-
dently affect capsule thickness. The adrenal capsule
gives rise to steroidogenic cells and is implicated in the
regulationofadrenal celldifferentiationandzonation.One
of the key pathways regulating this process is SHH sig-
naling (18). King et al. (18) demonstrated that removing
Shh signaling reduced the adrenal capsule thickness to a
single layer and suggested that SHH acted either as a
capsule cell mitogen/chemoattractant for noncapsule
mesenchyme or to maintain capsule progenitors. In
keepingwith this suggestion,we found thatMrap2/2mice
had up-regulated SHH expression and thickening of the
capsule. However, we also found ectopic SHH expression
throughout the cortex,which is not rescuedby lifetimeGC
replacement. Despite this failure to rescue, the capsule
thickness was reduced with GC treatment. This indicates
that SHH up-regulation was likely to be due to MRAP-
mediated ACTH resistance and not GC depletion. Fur-
thermore, there was dissociation between SHH signaling
and capsule thickness. This dissociation could be
explained by the lack of change in Gli1 expression levels
fromMrap2/2adrenalglands,perhapspointing toa lackof
increase in canonical hedgehog signaling in the cortex of
theseanimals.A thickenedcapsule is also seen inFgfrIIIb2/2
mice, although in this caseGli1 expression in the capsule is
increased (33). How the FGF, SHH, and ACTH signaling
co-ordinates the regulation of capsule thickness and pro-
genitor cell differentiation is subject to future investigations.
Another key signaling pathway implicated in the ad-
renal gland zonation regulation, the WNT4/b-catenin
pathway, was dysregulated in the adrenals of Mrap2/2
mice. The canonicalWNT4/b-catenin pathway is a driver
of ZG identity and is normally restricted to the sub-
capsular region, where it is coexpressed with SHH and
CYP11B2-positive cells (26, 27, 34). Mrap2/2 mice dem-
onstrated ectopic accumulation of WNT4/b-catenin
throughout the cortex, mirroring the SHH expression.
This is consistent with the hypothesis that ACTH signal-
ing via PKA inhibits the WNT4/b-catenin pathway (15).
However, a proportionof such cellswere negative for the
downstream target of the pathway LEF1, DAB2, and
CYP11B2, suggesting that, despite WNT4/b-catenin
accumulation, such cells do not contribute to aldosterone
production. This suggests that canonical WNT signaling
is not active in the inner cortical CYP11B2-negative cells
in the adrenal glands ofMrap2/2mice.
In summary, MRAP deficiency results in isolated GC
deficiency, making this a unique model replicating the
human FGD phenotype. We showed that the key path-
ways regulating adrenal zonation were dysregulated in
the adrenal glands of Mrap2/2 mice, demonstrating the
role ofMRAP-mediatedACTH signaling in the regulation
of adrenal progenitor cell differentiation (15, 23). Contrary
to current views, in this study we show that canonical
b-catenin through LEF1 does not always drive ZG iden-
tity. Our mouse model may point to noncanonical WNT
signaling pathways in adrenal gland zonation. Moreover,
GC replacement did not rescue the SHH or WNT4/
b-catenin pathway deregulation but decreased the thick-
ness of the adrenal capsule ofMrap2/2mice, indicating a
potential role for long-termGC treatment in regulating the
stemcellnichephysiologyinACTHresistancesyndromes.
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